HOME >> BIOLOGY >> NEWS
Yeast model shows promise as Alzheimer's test

A century ago this month, German psychiatrist Alois Alzheimer formally described characteristics of the neurodegenerative disease which ultimately came to bear his name. While international efforts to learn about Alzheimer's disease and develop treatments have progressed significantly in recent years, a cure remains an elusive goal.

A new research tool developed by Susan Liebman, distinguished university professor of biological sciences at the University of Illinois at Chicago, may ultimately provide a means for treating the earliest stage of Alzheimer's, thereby stemming its progression.

Alzheimer's disease is characterized by the formation of plaques in the brain largely composed of fibers made from a peptide called beta-amyloid, or A-beta, for short. There is abundant evidence to support the hypothesis that accumulation of A-beta peptide triggers the appearance of Alzheimer's. But while earlier research suggested the A-beta fiber caused Alzheimer's, recent research points at much smaller aggregates of the peptide as the culprit.

"We've developed a yeast model system in which A-beta small aggregate formation can be detected," said Liebman. "The system employs a fusion of the human A-beta peptide to a functional yeast protein, called a reporter protein, which is only active in allowing cells to grow on test media if the fusion does not form aggregates."

Liebman said the yeast model system can be used to develop a high throughput assay to screen small molecules to find those that inhibit the A-beta dependent aggregation. "We'll screen a library of drugs and compounds, looking for ones that allow our yeast with the reporter protein to grow."

She said after the assay conditions are perfected, the screen will be ready for an automated process that will allow for fast testing of many compounds. Medicinal chemists would then study the structures of compounds that pass the screen and design compounds that enhance the activ
'"/>

Contact: Paul Francuch
francuch@uic.edu
312-996-3457
University of Illinois at Chicago
17-Nov-2006


Page: 1 2

Related biology news :

1. Yeast discovery gives insight into familial dysautonomia
2. Yeast finding links processes in heart disease and cancer
3. Yeast network prevents damage by oxygen radicals
4. Huntingtons disease study shows animal models on target
5. Stem cell therapy rescues motor neurons in ALS model
6. MIT model could predict cells response to drugs
7. Drug protects brain cells in Huntingtons disease model, researchers find
8. New model for autism suggests women carry the disorder and explains age as a risk factor
9. New treatment model for HIV
10. A first-principles model of early evolution
11. Virginia Tech researchers to study poplar tree as model biomass crop

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/14/2019)... ... 2019 , ... Join the live session on ... topics in data quality, including:, ,     State of the art ...     Smartphone and wearable based performance measures ,     Data quality analytics ...
(Date:1/10/2019)... ... 10, 2019 , ... When Dr. James L. Sherley, M.D., Ph.D., founder and ... a chapter to the new book Perinatal Stem Cells: Research and Therapy, he knew ... a debilitating secret of stem cell medicine. For more than a half-century, stem ...
(Date:1/8/2019)... ... January 07, 2019 , ... Join industry experts Julie Peacock, Client Services at ... on Thursday, January 17, 2019 at 1pm EST. , This webinar will ... clinical trial process. Featured speakers will also present a case study of a leading ...
Breaking Biology News(10 mins):
(Date:1/7/2019)... ... 07, 2019 , ... Kainos Medicine Inc. today announced that ... code-named "KM-819." KM-819 is an orally active small molecule that is a ... , This Phase 1 randomized, double-blind, placebo-controlled dose-escalation study was to evaluate ...
(Date:1/4/2019)... DIEGO (PRWEB) , ... January 03, 2019 , ... ... at the forefront of oncolytic virus-based immunotherapies for cancer, today announced the founding ... Biotherapeutics to receive critical input and guidance from key leaders in the Immuno-Oncology ...
(Date:12/18/2018)... (PRWEB) , ... December 17, 2018 , ... ... today the second cohort of emerging biosciences ventures invited to participate in the ... education to develop fundable business plans and a professional network. All startups receive ...
(Date:12/13/2018)... , ... December 11, 2018 , ... ... doctors and nurses can use to quickly detect Clostridium difficile (C. diff), a ... heart of a handheld device that can be used onsite in doctor’s offices ...
Breaking Biology Technology:
Cached News: